In Vitro And In Vivo Screening of chemopreventive agents
In Vitro And In Vivo Screening of chemopreventive agents
批准号:
7902363
负责人:
DAVID MCCORMICK
金额:
$101.71万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-30 至 2011-04-29
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This Master Agreement proposal is designed to establish and identify the most proficent chemopreventive agent and conditions that will inhibit, reverse or delay cancer. The work under this master agreement proposal is carried out in coordination with the NCI, in the Division of Cancer Prevention (DCP), using state of the art , mechanism-based models, such that insight may be gained about cancer prevention and control in man.
The proposal will provide screening and identification of potential cancer preventive agents in mechanism-based in vitro and in vivo assays.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Base Title: PREVENT Preclinical Pharmacology and ToxicologyTask Order Title: Nicotine Reduction Therapy Using the Human Monoclonal Antibody ATI-1013
-
批准号:10932479
-
项目类别:
-
资助金额:$65.95万
-
财政年份:2023
-
负责人:DAVID MCCORMICK
-
依托单位:
CONTRACT ORIENTATION & KICKOFF MEETING FOR R&D SERVICES UNDER "PRECLINICAL TOXICOLOGY OF SMALL MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIO
-
批准号:10710462
-
项目类别:
-
资助金额:$0.3万
-
财政年份:2022
-
负责人:DAVID MCCORMICK
-
依托单位:
PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS
-
批准号:10802090
-
项目类别:
-
资助金额:$145.68万
-
财政年份:2022
-
负责人:DAVID MCCORMICK
-
依托单位:
PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS
-
批准号:10605054
-
项目类别:
-
资助金额:$75.0万
-
财政年份:2022
-
负责人:DAVID MCCORMICK
-
依托单位:
TASK ORDER: TOPICAL RESATORVID FOR NONMELANOMA SKIN CANCER PREVENTIONPERIOD OF PERFORMANCE: 09/21/2020 - 03/31/2023
-
批准号:10551020
-
项目类别:
-
资助金额:$15.66万
-
财政年份:2020
-
负责人:DAVID MCCORMICK
-
依托单位:
PREVENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS; TASK ORDER TITLE: PRECLINICAL DEVELOPMENT OF AN RNA VACCINE FOR IMMUNOPREV
-
批准号:10269186
-
项目类别:
-
资助金额:$43.04万
-
财政年份:2020
-
负责人:DAVID MCCORMICK
-
依托单位:
PREVENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS; TASK ORDER TITLE: PRECLINICAL DEVELOPMENT OF AN RNA VACCINE FOR IMMUNOPREV
-
批准号:10598444
-
项目类别:
-
资助金额:$29.14万
-
财政年份:2020
-
负责人:DAVID MCCORMICK
-
依托单位:
COVID-19 RELATED STUDY INVOLVING DOGS
-
批准号:10269151
-
项目类别:
-
资助金额:$59.79万
-
财政年份:2020
-
负责人:DAVID MCCORMICK
-
依托单位:
TASK ORDER: TOPICAL RESATORVID FOR NONMELANOMA SKIN CANCER PREVENTIONPERIOD OF PERFORMANCE: 09/21/2020 - 03/20/2022
-
批准号:10269127
-
项目类别:
-
资助金额:$21.32万
-
财政年份:2020
-
负责人:DAVID MCCORMICK
-
依托单位:
TASK ORDER: TOPICAL RESATORVID FOR NONMELANOMA SKIN CANCER PREVENTIONPERIOD OF PERFORMANCE: 09/21/2020 - 03/31/2023
-
批准号:10817653
-
项目类别:
-
资助金额:$64.46万
-
财政年份:2020
-
负责人:DAVID MCCORMICK
-
依托单位:
SUPPORT FOR THE PRECLINICAL DEVELOPMENT OF EIF4A INHIBITORS ROCAGLAMIDE AND DIDESMETHYLROCAGLAMIDE. (TOXICIOLOGY SERVICES TO SUPPORT PRECLINICAL DRUG
-
批准号:10281213
-
项目类别:
-
资助金额:$58.86万
-
财政年份:2020
-
负责人:DAVID MCCORMICK
-
依托单位:
"CONTRACT ORIENTATION AND KICKOFF MEETING", TASK ORDER #1 UNDER 75N91019D00012. TASK ORDER PERIOD OF PERFORMANCE: 1/25/2019-2/24/2019.
-
批准号:10019025
-
项目类别:
-
资助金额:$0.35万
-
财政年份:2019
-
负责人:DAVID MCCORMICK
-
依托单位:
IGF::OT::IGF CONTRACT ORIENTATION KICKOFF MEETING PP: 9/22/2015 TO 12/31/2015
-
批准号:9152942
-
项目类别:
-
资助金额:$0.45万
-
财政年份:2015
-
负责人:DAVID MCCORMICK
-
依托单位:
In Vitro And In Vivo Screening of chemopreventive agents
-
批准号:8151535
-
项目类别:
-
资助金额:$104.76万
-
财政年份:2004
-
负责人:DAVID MCCORMICK
-
依托单位:
PRECLINICAL IN VITRO AND IN VIVO SCREENING ASSAYS FOR CANCER PREVENTIVE AGENT DE
-
批准号:7543337
-
项目类别:
-
资助金额:$92.4万
-
财政年份:2004
-
负责人:DAVID MCCORMICK
-
依托单位:--
PRECLINICAL TOXICOLOGY AND PHARMACOLOGY OF DRUGS DEVELOPED FOR CANCER, AIDS, AND
-
批准号:7543410
-
项目类别:
-
资助金额:$127.22万
-
财政年份:2004
-
负责人:DAVID MCCORMICK
-
依托单位:--
Preclinical Toxicology and Pharmacology of Drugs for Cancer
-
批准号:8328549
-
项目类别:
-
资助金额:$25.83万
-
财政年份:2004
-
负责人:DAVID MCCORMICK
-
依托单位:
Preclinical Toxicology and Pharmacology of Drugs for Cancer
-
批准号:8014415
-
项目类别:
-
资助金额:$700.0万
-
财政年份:2004
-
负责人:DAVID MCCORMICK
-
依托单位:
Preclinical Toxicology and Pharmacology of Drugs for Cancer
-
批准号:8177666
-
项目类别:
-
资助金额:$132.28万
-
财政年份:2004
-
负责人:DAVID MCCORMICK
-
依托单位:
PRECLINICAL PHARMACOLOGY AND TOXICOLOGY STUDIES -26133004C
-
批准号:6994846
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:DAVID MCCORMICK
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于ex vivo模型联合多组学手段绘制胃癌曲妥珠单抗继发耐药机制并探索克服耐药策略
-
批准号:82072728
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:高静
-
依托单位:
神经干细胞治疗帕金森病大鼠模型:在体(in vivo)实时记录纹状体多巴胺分泌
-
批准号:81571235
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:康新江
-
依托单位:
基于in vivo动力学分析的波动环境下黑曲霉产酶得率调控机制研究
-
批准号:21506052
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2015
-
负责人:夏建业
-
依托单位:
siRNA基因沉默与诱导双向基因治疗关节炎的软骨、滑膜生物学响应及ex vivo系统转基因在体示踪研究
-
批准号:81171774
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:张海宁
-
依托单位: